Korro Bio, Inc. Accounts Payable
Korro Bio, Inc. (KRRO) had Accounts Payable of $3.60 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $3.60M.
- 2026-03-31: Accounts Payable, Current $1.96M.
- 2025-12-31: Accounts Payable, Current $1.65M.
- 2025-09-30: Accounts Payable, Current $2.30M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.60M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.96M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $1.65M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $2.30M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $5.16M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $4.18M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $3.99M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $5.95M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $5.69M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $4.66M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $7.28M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $338.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.29M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.71M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $2.60M 10-K · filed 2024-03-26 | $3.11M 10-K · filed 2023-03-10 |
| 2022-09-30 | $4.01M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $3.55M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $2.25M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $2.75M 10-K · filed 2023-03-10 | |
| 2021-09-30 | $3.61M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $3.89M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $5.45M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $5.51M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $4.09M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $2.19M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $2.65M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.22M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $3.57M 10-Q · filed 2019-11-18 | |
| 2018-12-31 | $1.86M 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |